Bioreducible Carboxymethyl Dextran Nanoparticles for Tumor-Targeted Drug Delivery

Advanced Healthcare Materials

Volumn 3, Issue 11, 2014, Pages 1829-1838

  Thambi, Thavasyappan ^a   You, Dong Gil ^a,b   Han, Hwa Seung ^a   Deepagan, V G ^a   Jeon, Sang Min ^a   Suh, Yung Doug ^a,c   Choi, Ki Young ^b   Kim, Kwangmeyung ^b   Kwon, Ick Chan ^b   Yi, Gi Ra ^a   Lee, Jun Young ^a   Lee, Doo Sung ^a   Park, Jae Hyung ^a,c  

^a Sungkyunkwan University   (South Korea)

^b Korea Institute of Science and Technology   (South Korea)

^c Korea Research Institute of Chemical Technology   (South Korea)

Author keywords

Bioreducible nanoparticle; Carboxymethyl dextran; Doxorubicin; Drug delivery

Indexed keywords

CHEMICAL MODIFICATION; CONTROLLED DRUG DELIVERY; COVALENT BONDS; DEXTRAN; DISEASES; DRUG DELIVERY; DRUG PRODUCTS; FLUORESCENCE; LIFE CYCLE; MAMMALS; NANOPARTICLES; SULFUR COMPOUNDS; TUMORS;

CARBOXYMETHYL DEXTRAN; CARBOXYMETHYL DEXTRAN (CMD); CONFOCAL LASER SCANNING MICROSCOPY; DOXORUBICIN; INTRACELLULAR COMPARTMENTS; SELF ASSEMBLED NANOPARTICLES; SYSTEMIC ADMINISTRATION; TUMOR-TARGETED DRUG DELIVERIES;

TARGETED DRUG DELIVERY;

CARBOXYMETHYLDEXTRAN; DISULFIDE; DOXORUBICIN; DRUG CARRIER; GLUTATHIONE; LITHOCHOLIC ACID; NANOPARTICLE; ANTINEOPLASTIC AGENT; DEXTRAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; AQUEOUS SOLUTION; ARTICLE; CANCER CELL CULTURE; CELL NUCLEUS; CHEMICAL MODIFICATION; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DISULFIDE BOND; DRUG ACCUMULATION; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG STRUCTURE; DRUG TARGETING; FLUORESCENCE ANALYSIS; HYDROPHOBICITY; IN VITRO STUDY; IN VIVO STUDY; INCUBATION TIME; MOUSE; NANOENCAPSULATION; NONHUMAN; PARTICLE SIZE; PH; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; SUSTAINED DRUG RELEASE; TUMOR VOLUME; ANIMAL; CHEMICAL PHENOMENA; CHEMISTRY; METABOLISM; PROCEDURES; TISSUE DISTRIBUTION; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; DEXTRANS; DOXORUBICIN; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; GLUTATHIONE; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; MICE; NANOPARTICLES; PARTICLE SIZE; TISSUE DISTRIBUTION;

EID: 84922497258     PISSN: 21922640     EISSN: 21922659     Source Type: Journal    
DOI: 10.1002/adhm.201300691     Document Type: Article

References (52)

1. K. Y. Choi, H. Y. Yoon, J.-H. Kim, S. M. Bae, R.-W. Park, Y. M. Kang, I.-S. Kim, I. C. Kwon, K. Choi, S. Y. Jeong, K. Kim, J. H. Park, ACS Nano 2011, 5, 8591.
2. R. Duncan, Nat. Rev. Drug Discovery 2003, 2, 347.
3. D. Peer, J. M. Karp, S. Hong, O. C. Farokhzad, R. Margalit, R. Langer, Nat. Nanotechnol. 2007, 2, 751.
4. K. Y. Choi, K. H. Min, H. Y. Yoon, K. Kim, J. H. Park, I. C. Kwon, K. Choi, S. Y. Jeong, Biomaterials 2011, 32, 1880.
5. Y. Matsumura , H. Maeda , Cancer Res. 1986 , 46 , 6387.
6. H. Maeda , J. Wu , T. Sawa , Y. Matsumura , K. Hori , J. Controlled Release 2000 , 65 , 271.
7. K. H. Min, K. Park, Y.-S. Kim, S. M. Bae, S. Lee, H. G. Jo, R.-W. Park, I.-S. Kim, S. Y. Jeong, K. Kim, I. C. Kwon, J. Controlled Release 2008, 127, 208.
8. K. Y. Choi, K. H. Min, J. H. Na, K. Choi, K. Kim, J. H. Park, I. C. Kwon, S. Y. Jeong, J. Mater. Chem. 2009, 19, 4102.
9. X. Shuai, H. Ai, N. Nasongkla, S. Kim, J. Gao, J. Controlled Release 2004, 98, 415.
10. Y. Machida, H. Onishi, A. Kurita, H. Hata, A. Morikawa, J. Controlled Release 2000, 66, 159.
11. J.-H. Kim, Y.-S. Kim, K. Park, S. Lee, H. Y. Nam, K. H. Min, H. G. Jo, J. H. Park, K. Choi, S. Y. Jeong, R.-W. Park, I.-S. Kim, K. Kim, I. C. Kwon, J. Controlled Release 2008, 127, 41.
12. J. Chen, X. Qiu, J. Ouyang, J. Kong, W. Zhong, M. M. Q. Xing, Biomacromolecules 2011, 12, 3601.
13. J. Liu, Y. Pang, W. Huang, X. Huang, L. Meng, X. Zhu, Y. Zhou, D. Yan, Biomacromolecules 2011, 12, 1567.
14. M. Sanjoh, K. Miyata, R. J. Christie, T. Ishii, Y. Maeda, F. Pittella, S. Hiki, N. Nishiyama, K. Kataoka, Biomacromolecules 2012, 13, 3641.
15. L. Han, H. Ma, Y. Guo, Y. Kuang, X. He, C. Jiang, Adv. Healthcare Mater. 2013, 2, 1435.
16. Y. Li, G. H. Gao, D. S. Lee, Adv. Healthcare Mater. 2013, 2, 388
17. S. Mura, J. Nicolas, P. Couvreur, Nat. Mater. 2013, 12, 991.
18. K. T. Oh, H. Yin, E. S. Lee, Y. H. Bae, J. Mater. Chem. 2007, 17, 3987.
19. K. H. Min, J.-H. Kim, S. M. Bae, H. Shin, M. S. Kim, S. Park, H. Lee, R.-W. Park, I.-S. Kim, K. Kim, I. C. Kwon, S. Y. Jeong, D. S. Lee, J. Controlled Release 2010, 144, 259.
20. T. Thambi, V. G. Deepagan, C. K. Yoo, J. H. Park, Polymer 2011, 52, 4753.
21. E. R. Gillies, J. M. J. Fréchet, Bioconjugate Chem. 2005, 16, 361.
22. L. Song, V. H. B. Ho, C. Chen, Z. Yang, D. Liu, R. Chen, D. Zhou, Adv. Healthcare Mater. 2013, 2, 275.
23. S. Wen, H. Liu, H. Cai, M. Shen, X. Shi, Adv. Healthcare Mater. 2013, 2, 1267.
24. Y. Bae, S. Fukushima, A. Harada, K. Kataoka, Angew. Chem. Int. Ed. 2003, 42, 4640.
25. T. Thambi, V. G. Deepagan, H. Y. Yoon, H. S. Han, S.-H. Kim, S. Son, D.-G. Jo, C.-H. Ahn, Y. D. Suh, K. Kim, I. Chan Kwon, D. S. Lee, J. H. Park, Biomaterials 2014, 35, 1735.
26. S. Q. Liu, Y. W. Tong, Y.-Y. Yang, Biomaterials 2005, 26, 5064.
27. Y. Shamay, L. Adar, G. Ashkenasy, A. David, Biomaterials 2011, 32, 1377.
28. H. Zhang, H. Xia, J. Wang, Y. Li, J. Controlled Release 2009, 139, 31.
29. H. Sun, B. Guo, R. Cheng, F. Meng, H. Liu, Z. Zhong, Biomaterials 2009, 30, 6358.
30. H. Kim, S. Kim, C. Park, H. Lee, H. J. Park, C. Kim, Adv. Mater. 2010, 22, 4280.
31. R. Wei, L. Cheng, M. Zheng, R. Cheng, F. Meng, C. Deng, Z. Zhong, Biomacromolecules 2012, 13, 2429.
32. L.-Y. Tang, Y.-C. Wang, Y. Li, J.-Z. Du, J. Wang, Bioconjugate Chem. 2009, 20, 1095.
33. Y. Sun, X. Yan, T. Yuan, J. Liang, Y. Fan, Z. Gu, X. Zhang, Biomaterials 2010, 31, 7124.
34. H. Sun, B. Guo, X. Li, R. Cheng, F. Meng, H. Liu, Z. Zhong, Biomacromolecules 2010, 11, 848.
35. Y. Li, K. Xiao, J. Luo, W. Xiao, J. S. Lee, A. M. Gonik, J. Kato, T. A. Dong, K. S. Lam, Biomaterials 2011, 32, 6633.
36. D. P. Jones, J. L. Carlson, P. S. Samiec, P. Sternberg, V. C. Mody, R. L. Reed, L. A. S. Brown, Clin. Chim. Acta 1998, 275, 175.
37. A. N. Koo, H. J. Lee, S. E. Kim, J. H. Chang, C. Park, C. Kim, J. H. Park, S. C. Lee, Chem. Commun. 2008, 6570.
38. T. Thambi, H. Y. Yoon, K. Kim, I. C. Kwon, C. K. Yoo, J. H. Park, Bioconjugate Chem. 2011, 22, 1924.
39. T. Thambi, V. G. Deepagan, H. Ko, D. S. Lee, J. H. Park, J. Mater. Chem. 2012, 22, 22028.
40. T. Thambi, G. Saravanakumar, J.-U. Chu, R. Heo, H. Ko, V. Deepagan, J.-H. Kim, J. Park, Macromol. Res. 2013, 21, 100.
41. G. Shahnaz, G. Perera, D. Sakloetsakun, D. Rahmat, A. Bernkop-Schnürch, J. Controlled Release 2010, 144, 32.
42. D. P. McIntosh, R. J. Cooke, A. J. McLachlan, P. T. Daley-Yates, M. Rowland, J. Pharm. Sci. 1997, 86, 1478.
43. M. Baudyš, D. Letourneur, F. Liu, D. Mix, J. Jozefonvicz, S. W. Kim, Bioconjugate Chem. 1998, 9, 176.
44. F. Meng, W. E. Hennink, Z. Zhong, Biomaterials 2009, 30, 2180.
45. Y. W. Cho, S. A. Park, T. H. Han, D. H. Son, J. S. Park, S. J. Oh, D. H. Moon, K.-J. Cho, C.-H. Ahn, Y. Byun, I.-S. Kim, I. C. Kwon, S. Y. Kim, Biomaterials 2007, 28, 1236.
46. M. Sivasubramanian, T. Thambi, J. H. Park, Carbohydr. Polym. 2013, 97, 643.
47. M. Sivasubramanian, T. Thambi, V. G. Deepagan, G. Saravanakumar, H. Ko, Y. M. Kang, J. H. Park, J. Nanosci. Nanotechnol. 2013, 13, 7271.
48. S. Danson, D. Ferry, V. Alakhov, J. Margison, D. Kerr, D. Jowle, M. Brampton, G. Halbert, M. Ranson, Br. J. Cancer 2004, 90, 2085.
49. I. Brigger, C. Dubernet, P. Couvreur, Adv. Drug Delivery Rev. 2002, 54, 631.
50. V. P. Torchilin, Nat. Rev. Drug Discovery 2005, 4, 145.
51. K. Park, K. Kim, I. C. Kwon, S. K. Kim, S. Lee, D. Y. Lee, Y. Byun, Langmuir 2004, 20, 11726.
52. K. Kataoka, T. Matsumoto, M. Yokoyama, T. Okano, Y. Sakurai, S. Fukushima, K. Okamoto, G. S. Kwon, J. Controlled Release 2000, 64, 143.